Skip to content
Search

Latest Stories

Pharmacy First service to launch next year

Pharmacy First service to launch next year

The new Pharmacy First Common Ailments service will be launched in January 2024 

This Pharmacy First Common Ailments service will help patients seek treatment for seven common conditions directly from a pharmacy without the need for a GP appointment or prescription.


Launching on 31 January next year although it is subject to IT being ready, the service will cover ailments including “sinusitis, sore throat, earache, infected insect bites, impetigo, shingles, and uncomplicated urinary tract infections (UTIs)” in women.

People with symptoms of the above seven conditions will be supplied with a prescription-only treatment under a Patient Group Direction (PGD).

Patients seeking assistance at the pharmacy, whether walk-in or referred by NHS 111, GPs, or other sources, can receive consultations.

The new service includes self-referring patients plus referrals, and the Community Pharmacist Consultation Service (CPCS) will also be a part of it.

Pharmacy First - payments 

CPE's negotiations were also aimed at key improvements for the community pharmacy including aims to "incentivise sign-up for the new services, generate capacity, reduce risk for pharmacy owners and establish conditions for business growth."

They secured an upfront payment of £2,000 per pharmacy ahead of the Pharmacy First launch to support pharmacy owners in preparing and building capacity for the new service.

Moreover, pharmacy owners gaining access to advanced clinical IT systems is like unlocking a door to seamlessly share data with the NHSBSA's MYS portal and GP records.

This is a significant move to support for the ongoing growth and improvement of community pharmacy services.

There will be fixed £1,000 monthly payments subject to £15 per consultation to support ongoing capacity to deliver Pharmacy First.

The new tripartite implementation group (CPE, DHSC, NHSE) to scrutinise the uptake and activity volumes of Pharmacy First and to set caps for the second half of 2024-25.

CPE successfully negotiated eligibility for the £1,000 Pharmacy First monthly payment to the provision of the Hypertension Case-Finding and Pharmacy Contraception Services given the capacity issues in the sector.

Janet Morrison, Chief Executive of Community Pharmacy England, said: “Our focus will now turn to getting the money flowing to pharmacies and to preparing our long-term strategy to improve the sector’s future.

"Pharmacy First will help with this strategy, laying the foundations for future clinical services and establishing the sector as an increasingly vital part of primary care, offering an open door for the public and patients, relieving pressure and releasing capacity in other frontline NHS services," she said.

Morrison further added: "This is the future that the sector told Nuffield Trust and The King’s Fund that it wanted, and this was backed by our own summer polling in which 86 per cent of respondents said they were positive about delivering a  Pharmacy First service. We all now need to work together to make it a success, delivering real value to patients and the public using all our skills and capabilities."

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less